Legal & General Group
CSBR icon

Legal & General Group’s Champions Oncology CSBR Stock Holding History

Legal & General Group’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-690
Closed -$8K – 3525
2021
Q1 		$8K Sell
690
-129
-16% -$1.5K ﹤0.01% 3424
2020
Q4 		$9K Hold
819
– – ﹤0.01% 3362
2020
Q3 		$8K Sell
819
-362
-31% -$3.22K ﹤0.01% 3296
2020
Q2 		$11K Buy
+1,181
New +$10.1K ﹤0.01% 3281

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Legal & General Group's CSBR Position: Q2 2021 in Review

Legal & General Group sold out of Champions Oncology (CSBR) in Q2 2021, closing a stake of 690 shares — an estimated $8K sold.

Legal & General Group first reported a position in CSBR in Q2 2020 and held it in 4 quarters. The position peaked at $11K in Q2 2020. 38 funds tracked by Wall St. Rank hold CSBR as of Q2 2021.

  • Legal & General Group reported no remaining Champions Oncology position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 690 Champions Oncology shares in Q2 2021, an estimated $8K.
  • Legal & General Group first reported a position in Champions Oncology in Q2 2020 and held it in 4 quarters.
  • Legal & General Group's Champions Oncology position peaked at $11K in Q2 2020.
  • 38 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.